The US Department of Health and Human Services (HHS), working jointly with the Drug Enforcement Administration (DEA), today announced a fourth temporary extension of telemedicine flexibilities that allow patients to receive prescriptions for controlled medications without a prior in-person visit. The extension runs from January 1, 2026, through December 31, 2026, preventing disruptions in care while permanent rules are finalized. This action ensures that patients who rely on telemedicine — including seniors, rural residents, people with disabilities, and individuals receiving treatment for mental health conditions or substance use disorder — can continue accessing care without interruption.